Mimedx (MDXG) Amortization - Intangibles (2012 - 2026)
Mimedx (MDXG) reported Amortization - Intangibles of $301000.0 for Q1 2026, up 204.04% on a YoY basis from $99000.0 in Q1 2025, and up 133.33% sequentially from $129000.0 in Q4 2025.
Mimedx (MDXG) Amortization - Intangibles (2012 - 2026) Analysis & Trends
Mimedx (MDXG) has 15 years of Amortization - Intangibles data on file, last reported at $301000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization - Intangibles rose 204.04% year-over-year to $301000.0; the trailing twelve-month figure through Mar 2026 stood at $642000.0 (down 4.75% YoY), and the FY2025 full-year result was $439000.0, down 42.61% from the prior year.
- Amortization - Intangibles rose to $301000.0 in Q1 2026, from $129000.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $301000.0 in Q1 2026 to a low of $99000.0 in Q1 2025.
- A 5-year average of $174705.9 and a median of $189000.0 in 2024 frame the typical range for Amortization - Intangibles.
- Across the five-year window, Amortization - Intangibles sank 47.62% in 2025 and jumped 204.04% in 2026, its largest moves.
- Tracing MDXG's Amortization - Intangibles over 5 years: stood at $182000.0 in 2022, then rose by 5.49% to $192000.0 in 2023, then grew by 0.52% to $193000.0 in 2024, then slumped by 33.16% to $129000.0 in 2025, then soared by 133.33% to $301000.0 in 2026.
- Business Quant data shows MDXG's Amortization - Intangibles at $301000.0 in Q1 2026, $129000.0 in Q4 2025, and $112000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 301,000.00 |
| Dec 31, 2025 | 129,000.00 |
| Sep 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 192,000.00 |
| Jun 30, 2024 | 190,000.00 |
| Mar 31, 2024 | 189,000.00 |
| Dec 31, 2023 | 192,000.00 |
| Sep 30, 2023 | 190,000.00 |
| Jun 30, 2023 | 191,000.00 |
| Mar 31, 2023 | 190,000.00 |
| Dec 31, 2022 | 182,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 173,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 173,000.00 |
| Sep 30, 2021 | 193,000.00 |
| Jun 30, 2021 | 215,000.00 |